Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
SEC Accession No. 0001062993-22-010285
Filing Date
2022-04-15
Accepted
2022-04-14 21:56:36
Documents
5

Document Format Files

Seq Description Document Type Size
1 FORM F-1/A formf1a.htm F-1/A 2017548
2 EXHIBIT 23.1 exhibit23-1.htm EX-23.1 1369
3 GRAPHIC formf1ax001.jpg GRAPHIC 4609
4 GRAPHIC formf1axu002.jpg GRAPHIC 65770
5 GRAPHIC formf1axu003.jpg GRAPHIC 40371
  Complete submission text file 0001062993-22-010285.txt   2173033
Mailing Address SUITE 915 - 700 WEST PENDER STREET VANCOUVER A1 V6C 1G8
Business Address SUITE 915 - 700 WEST PENDER STREET VANCOUVER A1 V6C 1G8 604-646-1553
Algernon Pharmaceuticals Inc. (Filer) CIK: 0001642178 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0831
Type: F-1/A | Act: 33 | File No.: 333-262878 | Film No.: 22828865
SIC: 2834 Pharmaceutical Preparations